Advent Signs Confidentiality Agreement with Definitive Healthcare, Advancing Take-Private Talks
DH sits 53% above its 52-week low of $0.61.
Summary
Advent International signed a confidentiality agreement with Definitive Healthcare on September 29, 2026, formalizing the due-diligence phase of its $1.02 per share take-private proposal. The NDA includes a 12-month standstill and non-solicitation provisions.
Key Events · M&A and Partnerships · DH
-
Confidentiality Agreement Signed
Advent International, L.P. entered into a confidentiality agreement with Definitive Healthcare Corp. on September 29, 2026, to facilitate due diligence for a possible negotiated transaction.
-
Standstill and Non-Solicitation Terms
The NDA includes a 12-month standstill provision restricting acquisitions of securities, group formation, board representation, and proxy solicitation, plus a 12-month non-solicitation of executive officers.
-
Take-Private Process Advancing
Advent states it intends to continue engaging with the Special Committee and third parties, including founder Jason Krantz, regarding a transaction, following its September 2, 2026 proposal at $1.02 per share.
-
No New Share Transactions
The Reporting Persons have not effected any transactions in Common Stock since the filing of the Original Schedule 13D on September 2, 2026.
Analysis · DH · Technology
Advent International, which already owns 58.54% of Definitive Healthcare, has entered into a confidentiality agreement with the company as of September 29, 2026. The NDA includes a 12-month standstill provision and a 12-month non-solicitation of executives, and Advent states it intends to continue engaging with the Special Committee and third parties, including founder Jason Krantz, regarding a transaction. This formalizes the due-diligence phase of the previously announced $1.02 per share take-private proposal and signals that negotiations are progressing.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1661 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DH was trading at $0.94 on NASDAQ in the Technology sector, with a market capitalization of approximately $135.6M. The 52-week trading range was $0.61 to $4.02. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.